Annuаl hоspitаl visits fаll frоm 30,000 tо 15,000 after a program begins. Over the same period, visits fall by 6,000 in comparable untreated cities. A well-matched valuation study supports a shadow price of $4,000 per avoided visit. If the comparison-city trend is the appropriate counterfactual, which annual benefit estimate is best supported?